Compare BALY & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BALY | FLGT |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | 11700 | N/A |
| Industry | Hotels/Resorts | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.8M | 525.3M |
| IPO Year | 2019 | 2016 |
| Metric | BALY | FLGT |
|---|---|---|
| Price | $10.71 | $16.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $12.40 | ★ $28.33 |
| AVG Volume (30 Days) | 32.4K | ★ 529.1K |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,436,189,000.00 | $18,730,000.00 |
| Revenue This Year | $21.50 | $10.09 |
| Revenue Next Year | $5.45 | $12.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.46 | $13.46 |
| 52 Week High | $20.74 | $31.04 |
| Indicator | BALY | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 36.38 | 56.54 |
| Support Level | $8.91 | $13.91 |
| Resistance Level | $14.08 | $16.70 |
| Average True Range (ATR) | 0.68 | 0.66 |
| MACD | -0.24 | 0.14 |
| Stochastic Oscillator | 18.17 | 97.48 |
Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.